Overview

Prediction of the Answer to the Treatment by Biotherapies for Naive Spondyloarthritis by Combinatorial Analysis of Serum Biomarkers

Status:
Completed

Trial end date:
2018-01-01

Target enrollment:

Participant gender:

Summary

The aim of this trial is the caracterisation of a predicting algorithm of the answering response for patients with etanercept treatment in spondyloarthritis disease. This algorithm will help to target patients patients who have a risk / benefit important for etanercept treatment.

Phase:

N/A

Details

Lead Sponsor:

University Hospital, Grenoble

Treatments:

Etanercept